CD44 and cancer: Choi D. S. et al. (2014) identified Chloroquine as a potential cancer stem cell (CSC) inhibitor through in silico gene expression signature analysis of the CD44(+)/CD24(-/low) CSC population in Triple-negative breast cancer (TNBC).